Caligan Partners LP → Anika Therapeutics, Inc. ANIK

Stake: 9.95% Shares: 1,435,130 CUSIP: 035255108 Class: Common Stock, par value $0.01 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 5.47

688,325 shares short · -3.4% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $558K

Point72 Asset Mgmt

Other Filings by Caligan Partners LP

Filed	Form	Issuer	Stake	Shares
2024-01-08	SC	STANDARD BIOTOOLS INC. LAB	—	—	view →
2023-07-03	SC	STANDARD BIOTOOLS INC. LAB	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →